EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Comparison of Disease Progression Between Amelanotic Melanoma and Melanotic Melanoma

Barzilai Aviv iD, Barnea Hamama Noa iD, Levin Lotan iD, Baum Sharon iD

Pigment Cell & Melanoma Research · 2026-05 · 39 (3)

DOI: 10.1111/pcmr.70083 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pigment Cell & Melanoma Research, online erschienen am 05.05.2026. Verfasst von Barzilai Aviv und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Melanoma, Amelanotic, Skin Neoplasms, Melanoma. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amelanotic melanoma lacks melanin and is more challenging to diagnose than pigmented melanoma, often leading to delayed detection and worse outcomes. We conducted a retrospective cohort study of 322 patients (28 with amelanotic melanoma and 294 with melanotic melanoma) treated at Sheba Medical Center between 2017 and 2023. Clinical features, treatment modalities, and 1‐year outcomes were analyzed. Tumor stage at diagnosis was the strongest predictor of remission, disease progression, and mortality in both groups. Pigmentation was associated with a higher likelihood of treatment modification ( p = 0.02) and showed a borderline association with progression ( p = 0.08). Subgroup analysis by stage revealed no significant outcome differences except for increased therapy change in stage 2 melanotic melanoma. The findings reinforce the importance of early detection, especially in amelanotic melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Melanoma, AmelanoticSkin NeoplasmsMelanomaHumansDisease ProgressionFemaleMaleMiddle AgedAgedAdult

Autor:innen und Institutionen

  • Department of Dermatology, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel.
  • Institute of Pathology, Sheba Medical Center, Tel Aviv, Israel.
  • Gray Faculty of Medical and Health Sciences, Tel Aviv, Israel.

ORCID-Profile: Barzilai Aviv, Barnea Hamama Noa, Levin Lotan, Baum Sharon

Zitieren

APA

Aviv, B., Noa, B. H., Lotan, L., & Sharon, B. (2026). Comparison of Disease Progression Between Amelanotic Melanoma and Melanotic Melanoma. Pigment Cell & Melanoma Research, 39(3). https://doi.org/10.1111/pcmr.70083

Vancouver

Aviv B, Noa BH, Lotan L, Sharon B. Comparison of Disease Progression Between Amelanotic Melanoma and Melanotic Melanoma. Pigment Cell & Melanoma Research. 2026;39(3). doi:10.1111/pcmr.70083

BibTeX
@article{Aviv2026,
  author = {Aviv, Barzilai and Noa, Barnea Hamama and Lotan, Levin and Sharon, Baum},
  title = {Comparison of Disease Progression Between Amelanotic Melanoma and Melanotic Melanoma},
  journal = {Pigment Cell & Melanoma Research},
  year = {2026},
  volume = {39},
  number = {3},
  doi = {10.1111/pcmr.70083}
}
Kostenlos starten →